January 2018

Important New Products

• Praluent (alirocumab (rch)) is a fully human monoclonal antibody that binds with high affinity ...(more)
• Zinplava (bezlotoxumab (rch)) is a specific fully human monoclonal antibody that binds with ...(more)

New Contraindications

• Gopten (trandolapril) is now contraindicated with concomitant neprilysin (neutral ...(more)
• Priorix (measles, mumps and rubella vaccine (live, attenuated)) and Priorix-Tetra ...(more)
• Coadministration of Stribild (tenofovir disoproxil fumarate/emtricitabine/elvitegravir/ ...(more)
• Coadministration of Viekira Pak (paritaprevir/ritonavir/ombitasvir/dasabuvir) and ...(more)

Active Ingredient Naming Changes

In this release, MIMS Australia will be including the following INNs (International Non-proprietary Names) as well as Australian Approved Names (AANs) as part of our push to support the Therapeutic Goods Administration (TGA) active ingredient name changes project.  

MIMS will begin referring to these ingredients by their new names, however, users may continue to search by the old AANs if preferred. ...(more)